Agenus
AGEN
#9035
Rank
A$0.20 B
Marketcap
A$5.33
Share price
-1.79%
Change (1 day)
20.06%
Change (1 year)

Earnings for Agenus (AGEN)

Earnings in 2025 (TTM): A$27.43 Million

According to Agenus 's latest financial reports the company's current earnings are A$0.10 Billion. In 2024 the company made an earning of -A$0.16 Billion, an increase over its 2023 earnings that were of -A$0.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Agenus from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$27.43 M-117.25%
2024 -A$0.16 Billion-28.13%
2023 -A$0.23 Billion-5.5%
2022 -A$0.24 Billion-556.26%
2021 A$51.32 M-130.37%
2020 -A$0.17 Billion73.75%
2019 -A$97.27 Million-48.74%
2018 -A$0.19 Billion34.32%
2017 -A$0.15 Billion-7.16%
2016 -A$0.16 Billion26.55%
2015 -A$0.13 Billion110.24%
2014 -A$57.2 Million49.12%
2013 -A$38.36 Million
2011 -A$26.48 Million-12.25%
2010 -A$30.18 Million-21.41%
2009 -A$38.4 Million-26.86%
2008 -A$52.51 Million13.72%
2007 -A$46.17 Million-33.4%
2006 -A$69.33 Million-31.84%
2005 -A$0.11 Billion9.74%
2004 -A$92.68 Million-0.8%
2003 -A$93.43 Million17.37%
2002 -A$79.6 Million37.83%
2001 -A$57.75 Million55.99%
2000 -A$37.03 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$46.54 B 162,277.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$31.10 B 108,417.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$12.94 B 45,043.49%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$13.72 B 47,791.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
-A$0.4 Billion-1,490.73%๐Ÿ‡บ๐Ÿ‡ธ USA